Dermatology News

Two phase 3 trials found that lebrikizumab was effective against moderate-to-severe atopic dermatitis in adolescents and adults, researchers reported in The New England Journal of Medicine.

You are asked to see a 14-year-old girl for recurrent, draining sores in the bilateral groin areas for over a year. She did not want to tell her parents, fearing what they might think, even though she was not sexually active.

The FDA has accepted a new drug application for Novan’s berdazimer gel for the treatment of molluscum contagiosum, the company announced in a press release.

A combination therapy of IV doxycycline and azithromycin was more effective for the treatment of severe scrub typhus than using either drug alone, according to findings published Wednesday in The New England Journal of Medicine.

MIAMI BEACH, Fla. — One of the main challenges of treating adolescent patients with acne is adherence, creating a need for practitioners to be cognizant and work with patients to increase prescribed usage, according to a presenter here.

MIAMI BEACH, Fla. — Treatment options for alopecia areata are expanding, but practitioners with pediatric patients should be cognizant of what is appropriate for young individuals, according to a presenter here.

The FDA has approved a supplemental biologics license application to expand the use of lanadelumab-flyo for prophylaxis of hereditary angioedema attacks in children aged 2 to younger than 12 years, according to a press release.

A 12-year-old girl presents to the guest columnist’s office with a red, painful right auricle. The onset was yesterday, and it is worse today.

A previously healthy 8-year-old boy dropped a 5-pound dumbbell on his right foot. After the accident, there was immediate pain, followed by swelling and erythema.

The 35th annual Infectious Diseases in Children Symposium will be held Nov. 19 and 20 in New York.